Lantsman Iu V, Anisenia I I, Shagiakhmetova R A, Vaks L P
Vopr Onkol. 1991;37(4):479-84.
The data on 76 patients treated for benign or malignant giant-cell tumor (GCT) of the bone are presented. Surgery involving bone reconstruction and endoprosthetics was the basic therapeutic procedure. Cases with lytic benign GCT received 36-40 Gy of radiation prior to surgery whereas whose with malignant tumors were subjected to complex treatment including preoperative irradiation, surgery and chemotherapy. Recurrence was observed in two patients with benign and in one--with malignant GCT. There were four fatalities. Five-year survival was 82%.
本文呈现了76例接受骨良性或恶性巨细胞瘤（GCT）治疗患者的数据。涉及骨重建和内置假体的手术是基本治疗手段。溶骨性良性GCT患者在手术前接受36 - 40 Gy的放疗，而恶性肿瘤患者则接受包括术前放疗、手术和化疗的综合治疗。2例良性GCT患者和1例恶性GCT患者出现复发。有4例死亡。五年生存率为82%。
